Genotype analysis of the CYP2C19 gene in the Japanese population

Life Sciences

Volumn 59, Issue 20, 1996, Pages 1711-1715

  Tsuneoka, Yutaka ^a   Fukushima, Kouji ^a   Matsuo, Yoshinori ^b   Ichikawa, Yoshiyuki ^c   Watanabe, Yasuhiro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c KAGAWA UNIVERSITY   (Japan)

Author keywords

CYP2C19; genotype; mephenytoin hydroxylase; polymorphism

Indexed keywords

CYTOCHROME P450 ISOENZYME; DNA; MEPHENYTOIN;

ARTICLE; AUTOIMMUNE HEPATITIS; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG METABOLISM; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LUNG CANCER; MAJOR CLINICAL STUDY; MUTATION; PARKINSON DISEASE; POPULATION RESEARCH; PRIMARY BILIARY CIRRHOSIS; RANDOMIZED CONTROLLED TRIAL;

ARYL HYDROCARBON HYDROXYLASES; CARCINOMA, SQUAMOUS CELL; CYTOCHROME P-450 ENZYME SYSTEM; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; JAPAN; LIVER DISEASES; LUNG NEOPLASMS; MIXED FUNCTION OXYGENASES; PARKINSON DISEASE; POLYMORPHISM, GENETIC;

EID: 0030580125     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(96)00507-3     Document Type: Article

References (13)

1. 1. A. KUPFER and R. PRESIG, Eur. J. Clin. Pharmacol. 26 753-759 (1984).
2. 2. P.J. WEDLUND, W.S. ASLANIAN, C.B. MCALLISTER, G.R. WILKINSON and R.A. BRANCH, Clin. Pharmacol. Ther. 36 773-780 (1984).
3. 3. T. ANDERSSON, C.G. REGARDH, Y.C. LOU, Y. ZHANG, M.L. DAHL and L. BERTILSSON, Pharmacogenetics 2 25-31 (1992).
4. 4. S.A. WARD, T. WALLE, U.K. WALLE, G.R. WILKINSON and R.A. BRANCH, Clin. Pharmacol. Ther. 45 72-79 (1989).
5. 5. J.A. GOLDSTEIN and S.M.F. DE MORAIS, Pharmacogenetics. 4 285-299 (1994).
6. 6. K. NAKAMURA, F. GOTO, W.A. RAY, C.B. MCALLISTER, E. JACQZ, G.R. WILKINSON and R.A. BRANCH, Clin. Pharmacol. Ther. 38 402-408 (1985).
7. 7. G.R. WILKINSON, F.P. GUENGERICH and R.A. BRANCH, Pharmacol. Ther. 43 53-76 (1989).
8. 8. R. AYESH, J.R. IDLE, J.C. RITCHIE, M.J. CROTHERS and M.R. HETZEL, Nature 312 169-170 (1984).
9. 9. S.M.F. DE MORAIS, G.R. WILKINSON, J. BLAISDELL, K. NAKAMURA, U.A. MEYER and J.A. GOLDSTEIN, J. Biol. Chem. 269 15419-15422 (1994).
10. 10. S.M.F. DE MORAIS, G.R. WILKINSON, J. BLAISDELL, U.A. MEYER, K. NAKAMURA and J.A. GOLDSTEIN, Mol. Pharmacol. 46 594-598 (1994).
11. 11. Y.W. KAN and A.M. DOZY, Proc. Natl. Acad. Sci. USA 75 5631-5635 (1978).
12. 12. C.J. SPEIRS, S. MURRAY, D.S. DAVIES, A.F. BIOLA MABADEJE and A.R. BOOBIS, Br. J. Clin. Pharmac. 29 101-109 (1990).
13. 13. K.M. SEMCHUK, E.J. LOVE and R.G. LEE, Neurology. 42 1328-1335 (1992).